Marksans Pharma Limited (BOM:524404)

Marksans Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	83,369	100,815	68,836	31,903	18,627	20,445
Market Cap Growth	-40.53%	46.46%	115.77%	71.27%	-8.89%	259.35%
Enterprise Value	80,272	96,315	63,549	29,746	16,052	19,467
Last Close Price	183.95	221.57	150.71	69.71	44.83	48.99
PE Ratio	23.71	26.49	21.94	11.98	9.97	8.57
PS Ratio	3.05	3.84	3.16	1.72	1.25	1.49
PB Ratio	3.07	4.05	3.30	1.81	1.52	2.26
P/TBV Ratio	3.27	4.28	3.51	1.95	1.67	2.50
P/FCF Ratio	241.03	298.76	319.14	17.36	35.20	15.47
P/OCF Ratio	40.72	48.78	29.88	13.44	18.77	11.45
EV/Sales Ratio	2.94	3.67	2.92	1.61	1.08	1.42
EV/EBITDA Ratio	16.13	19.21	14.65	9.29	6.68	5.81
EV/EBIT Ratio	19.84	21.63	16.54	10.34	7.50	6.30
EV/FCF Ratio	232.07	285.42	294.63	16.19	30.33	14.73
Debt / Equity Ratio	0.12	0.13	0.12	0.07	0.09	0.04
Debt / EBITDA Ratio	0.67	0.61	0.53	0.36	0.43	0.12
Debt / FCF Ratio	9.60	9.54	11.32	0.67	2.09	0.30
Asset Turnover	0.86	0.89	0.89	0.97	1.04	1.29
Inventory Turnover	1.46	1.64	1.95	2.07	1.76	1.87
Quick Ratio	2.85	2.64	2.99	3.34	2.09	1.62
Current Ratio	5.18	4.62	4.78	4.91	3.37	3.02
Return on Equity (ROE)	14.07%	16.73%	16.35%	17.76%	17.55%	30.69%
Return on Assets (ROA)	7.96%	9.40%	9.86%	9.39%	9.33%	18.13%
Return on Capital (ROIC)	9.11%	10.82%	11.39%	11.16%	11.75%	23.74%
Return on Capital Employed (ROCE)	13.50%	16.10%	16.80%	15.60%	16.70%	33.30%
Earnings Yield	4.22%	3.77%	4.56%	8.35%	10.03%	11.67%
FCF Yield	0.41%	0.34%	0.31%	5.76%	2.84%	6.46%
Dividend Yield	0.42%	0.36%	0.40%	0.72%	0.56%	0.51%
Payout Ratio	10.31%	7.14%	7.22%	3.82%	5.67%	1.72%
Buyback Yield / Dilution	0.02%	-	-9.09%	-1.49%	-	0.00%
Total Shareholder Return	0.44%	0.36%	-8.69%	-0.77%	0.56%	0.51%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.